Aster Capital Management (Difc) LTD Iovance Biotherapeutics, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $540 Billion
- Q1 2025
A detailed history of Aster Capital Management (Difc) LTD transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 754 shares of IOVA stock, worth $1,327. This represents 0.0% of its overall portfolio holdings.
Number of Shares
754Holding current value
$1,327% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
334Shares Held
247MCall Options Held
1.34MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA27.8MShares$48.9 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$43 Million12.15% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$37.4 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$22.4 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$19.4 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $278M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...